Moderna, Inc.($(MRNA)$)$ $(NVAX)$Just a delay, if you have patience, NVAX will back to 300 by end of next quarter IMO! Specially if Variants are still big issueBetter Efficacy/Safety than $MRNA I hear.
精彩评论